TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36452042

Group type: EXPERIMENTAL
Intervention: TAU + FIBRO‐On
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: TAU + FIBRO‐Out
Number of subjects: 225

Group type: COMPARATOR
Intervention: TAU
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: FIBRO‐On and FIBRO‐Out
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Quality of life and costs
Number of subjects: 225
Study: 33383206

Group type: EXPERIMENTAL
Intervention: 3.8 % SDF + RMGIC + DD
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 0.25 % GO + RMGIC + DD
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (unconditioned specimens)
Number of subjects: 80
Study: 32501897

Group type: EXPERIMENTAL
Intervention: Gene therapy for Lebers Congenital Amaurosis
Number of subjects: 0
Study: 33258274

Group type: EXPERIMENTAL
Intervention: Nap (near darkness)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bright light (1,200 lx, 4,000 K at eye level)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (200 lx, 4,000 K at eye level)
Number of subjects: 0
Study: 32574895

Group type: EXPERIMENTAL
Intervention: HARMONIC ACE® + 23 cm shears (HS)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Monopolar electrocautery (EC)
Number of subjects: 20
Study: 34032803

Group type: EXPERIMENTAL
Intervention: Guided internet delivered cognitive behavioural treatment (CBT) for insomnia
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Meaning‐centred group psychotherapy targeting personal meaning for cancer survivors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Internet‐based CBT treatment for persons with diabetes with elevated depressive symptoms
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control groups
Number of subjects: 0
Study: 32621141

Group type: EXPERIMENTAL
Intervention: Intramedullary nails
Number of subjects: 154

Group type: COMPARATOR
Intervention: Minimally invasive plate osteosynthesis
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Fixation of fibula
Number of subjects: 154

Group type: COMPARATOR
Intervention: Plating of fibula
Number of subjects: 154
Study: 34587358

Group type: EXPERIMENTAL
Intervention: TCI633 supplementation (two tablets daily for 8 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34379443

Group type: EXPERIMENTAL
Intervention: Gemcitabine plus Cisplatin (GP)
Number of subjects: 362

Group type: COMPARATOR
Intervention: Fluorouracil plus Cisplatin (FP)
Number of subjects: 362
Study: 32252100

Group type: EXPERIMENTAL
Intervention: Combined muscle training (CombT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (IMT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Expiratory muscle training (EMT)
Number of subjects: 0
Study: 35791588

Group type: EXPERIMENTAL
Intervention: Compound glycyrrhizin
Number of subjects: 100

Group type: COMPARATOR
Intervention: Desloratadine citrate combined with compound glycyrrhizin
Number of subjects: 100
Study: 34587253

Group type: EXPERIMENTAL
Intervention: 10-week portfolio diet of proposed anti-inflammatory foods (high intake of fatty fish, whole grains, fruits, nuts, and berries)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 10-week portfolio diet of proposed anti-inflammatory foods
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control diet resembling a Western diet
Number of subjects: 50
Study: 36242544

Group type: EXPERIMENTAL
Intervention: Prism therapy using 20 dioptre prism lenses for repeated aiming for 12 sessions
Number of subjects: 74

Group type: COMPARATOR
Intervention: Neutral lenses for aiming training (Control group)
Number of subjects: 74
Study: 34444313

Group type: EXPERIMENTAL
Intervention: Experimental condition (disaster experience)
Number of subjects: 214

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Mortality salience
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Gratitude
Number of subjects: 214
Study: 34026421

Group type: EXPERIMENTAL
Intervention: Randomization to receive a housing voucher
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Change in school district (mediated effect)
Number of subjects: 0
Study: 35794433

Group type: EXPERIMENTAL
Intervention: Patient-Controlled Caudal Epidural Analgesia (PCCA)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Patient-Controlled Intravenous Analgesia (PCIA)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study: 33069847

Group type: EXPERIMENTAL
Intervention: Bioresorbable vascular scaffold (BVS) plus guideline-directed medical therapy (GDMT)
Number of subjects: 182

Group type: COMPARATOR
Intervention: GDMT alone
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: BVS
Number of subjects: 182
Study: 36437688

Group type: EXPERIMENTAL
Intervention: TRV027
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 35268099

Group type: EXPERIMENTAL
Intervention: Probiotic (Streptococcus salivarius K12)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 34464304

Group type: EXPERIMENTAL
Intervention: Preoperative physical therapy education program
Number of subjects: 50

Group type: COMPARATOR
Intervention: Routine preparation for the procedure (Control)
Number of subjects: 50
Study: 34319914

Group type: EXPERIMENTAL
Intervention: Covert stroke (DWI-detected ischemic injury)
Number of subjects: 164

Group type: COMPARATOR
Intervention: No covert stroke
Number of subjects: 164
Study: 32621918

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine pretreatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: 0.9% NaCl (Control)
Number of subjects: 0
Study: 34112719

Group type: EXPERIMENTAL
Intervention: Cooled (therapeutic hypothermia)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Non-cooled (no therapeutic hypothermia)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: MRI (moderate/severe basal ganglia and thalami injury)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: MRI (absent/equivocal signal in the posterior limb of the internal capsule)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: GMA (absent fidgety movements)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: MRI (normal/mild BGT injury)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: MRI (normal PLIC)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: GMA (present fidgety movements)
Number of subjects: 50
Study: 34626956

Group type: EXPERIMENTAL
Intervention: Partially hydrolyzed protein formula (pHF) with synbiotics (scGOS/lcFOS; 9:1) and Bifidobacterium breve M‐16V
Number of subjects: 112

Group type: COMPARATOR
Intervention: Intact protein infant formula (IF) with scGOS/lcFOS
Number of subjects: 112

Group type: COMPARATOR
Intervention: Breastfed reference group
Number of subjects: 112

Group type: COMPARATOR
Intervention: Both formula groups (test and control)
Number of subjects: 112
Study: 35617986

Group type: EXPERIMENTAL
Intervention: Baricitinib plus remdesivir plus placebo
Number of subjects: 1010

Group type: COMPARATOR
Intervention: Dexamethasone plus remdesivir plus placebo
Number of subjects: 1010
Study: 33674187

Group type: EXPERIMENTAL
Intervention: Chemotherapy in 6-IHC score 'High' risk group
Number of subjects: 330

Group type: COMPARATOR
Intervention: No chemotherapy in 6-IHC score 'Low' risk group
Number of subjects: 330
Study: 32678376

Group type: EXPERIMENTAL
Intervention: Weighted blanket during chemotherapy infusion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no weighted blanket during chemotherapy infusion)
Number of subjects: 0
Study: 33891981

Group type: EXPERIMENTAL
Intervention: Anti-IL-22 (fezakinumab [FZ]) treatment for 12 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 34841959

Group type: EXPERIMENTAL
Intervention: Diet-Coke (AS)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Coca-Cola (NS)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Water (CON)
Number of subjects: 8
Study: 33594802

Group type: EXPERIMENTAL
Intervention: Multiple micronutrients (MMN) supplementation before 12 gestational weeks
Number of subjects: 18775

Group type: EXPERIMENTAL
Intervention: Multiple micronutrients (MMN) supplementation early-onset (<28 weeks)
Number of subjects: 18775

Group type: EXPERIMENTAL
Intervention: Multiple micronutrients (MMN) supplementation late-onset (≥28 weeks)
Number of subjects: 18775

Group type: COMPARATOR
Intervention: Folic acid (FA) supplementation
Number of subjects: 18775

Group type: COMPARATOR
Intervention: Iron–folic acid (IFA) supplementation
Number of subjects: 18775
Study: 32989261

Group type: EXPERIMENTAL
Intervention: Low-intensity shockwave therapy (LiST) - 5000 shockwaves per session with energy flux density 0.1 mJ/mm2, 6 sessions (once/week)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Sham treatment - 5000 shockwaves from a visually identical sham probe, 6 sessions (once/week)
Number of subjects: 45
Study: 36014806

Group type: EXPERIMENTAL
Intervention: DHA supplementation (200, 800, 1000 mg) during pregnancy
Number of subjects: 1145
Study: 33011163

Group type: EXPERIMENTAL
Intervention: Dynamic elastic intermaxillary fixation (IMF)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Wire intermaxillary fixation (IMF)
Number of subjects: 34
Study: 32480568

Group type: COMPARATOR
Intervention: Fog immersion alone
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Fog drip to the soil and canopy fog immersion
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (no fog water inputs)
Number of subjects: 10
Study: 34143979

Group type: EXPERIMENTAL
Intervention: Durvalumab/olaparib/paclitaxel (DOP)
Number of subjects: 372

Group type: COMPARATOR
Intervention: Standard of care (paclitaxel)
Number of subjects: 372
Study: 32329963

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Pioglitazone
Number of subjects: 98

Group type: COMPARATOR
Intervention: Glimepiride
Number of subjects: 98
Study: 33188493

Group type: EXPERIMENTAL
Intervention: Epidural dexmedetomidine (0.1% ropivacaine with 0.5 µg/mL dexmedetomidine)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Control group (0.1% ropivacaine alone)
Number of subjects: 600
Study: 32369570

Group type: EXPERIMENTAL
Intervention: Nonsurgical mechanical debridement with adjunct low-level laser therapy (LLLT)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Nonsurgical mechanical debridement alone
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Both groups (NSMD with LLLT and NSMD alone)
Number of subjects: 67
Study: 35122766

Group type: EXPERIMENTAL
Intervention: Higher induction regimen (adalimumab 160 mg at weeks 0, 1, 2, and 3)
Number of subjects: 514

Group type: COMPARATOR
Intervention: Standard induction regimen (adalimumab 160 mg at week 0 and 80 mg at week 2)
Number of subjects: 514

Group type: EXPERIMENTAL
Intervention: Clinically adjusted (CA) maintenance therapy
Number of subjects: 514

Group type: COMPARATOR
Intervention: Therapeutic drug monitoring (TDM) maintenance therapy
Number of subjects: 514
Study: 33861434

Group type: EXPERIMENTAL
Intervention: Curcumin at 250 mg daily for 2 months
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 34218961

Group type: EXPERIMENTAL
Intervention: ROTAVIN
Number of subjects: 825

Group type: COMPARATOR
Intervention: ROTAVIN‐M1
Number of subjects: 825

Group type: EXPERIMENTAL
Intervention: Both ROTAVIN and ROTAVIN‐M1
Number of subjects: 825
Study: 32251077

Group type: EXPERIMENTAL
Intervention: Peguero‐Lo Presti criteria
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Cornell criteria
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Sokolow‐‐Lyon voltage criteria
Number of subjects: 240

Group type: COMPARATOR
Intervention: All criteria
Number of subjects: 240
Study: 35367874

Group type: EXPERIMENTAL
Intervention: Mesenchymal stem cell (MSC) therapy
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 28
Study: 33762031

Group type: EXPERIMENTAL
Intervention: Vitamin D sufficient (25(OH)D ≥ 30 ng/mL)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Vitamin D insufficient (25(OH)D < 30 ng/mL)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Vitamin D levels above 27.16-30.69 ng/mL
Number of subjects: 300
Study: 34860745

Group type: EXPERIMENTAL
Intervention: Prognostic model incorporating 5 factors (brain lesions on MRI, previous nonspecific neurologic symptoms, low-dose corticosteroids treatment, ocular pain, absence of optic disc/peripapillary hemorrhage)
Number of subjects: 388

Group type: COMPARATOR
Intervention: Standard practice relying solely on brain lesions on MRI
Number of subjects: 388
Study: 33658473

Group type: EXPERIMENTAL
Intervention: 3M respirator
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: AoSafety (Medium) respirator
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: AoSafety (Large) respirator
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: AoSafety (All sizes) respirator
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: DUO respirator (one size fits all)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Climax respirator (one size fits all)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: AoSafety three-size system brands
Number of subjects: 41
Study: 35974393

Group type: EXPERIMENTAL
Intervention: Kinyarwanda version of the Diabetes-39 (D-39) questionnaire
Number of subjects: 309
Study: 32299284

Group type: EXPERIMENTAL
Intervention: Waived P2Y12 inhibitor copayment costs for 1 year
Number of subjects: 262

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 262

Group type: COMPARATOR
Intervention: Pre-study free medication programs
Number of subjects: 262
Study: 35894992

Group type: EXPERIMENTAL
Intervention: Yoga intervention
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Mindfulness and embodiment mechanisms
Number of subjects: 21
Study: 33137174

Group type: EXPERIMENTAL
Intervention: Contact precautions added to standard precautions during the intervention period (IP)
Number of subjects: 3283

Group type: COMPARATOR
Intervention: Standard precautions during the control period (CP)
Number of subjects: 3283
Study: 32396866

Group type: EXPERIMENTAL
Intervention: 50th percentile arm
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: 75th percentile arm
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: 50th percentile with forgiveness arm
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: 75th percentile with forgiveness arm
Number of subjects: 4
Study: 35462241

Group type: EXPERIMENTAL
Intervention: Cognitive Therapy (CT)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Behavior Therapy (BT)
Number of subjects: 128
Study: 33926747

Group type: EXPERIMENTAL
Intervention: Online parenting education via WhatsApp
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 32
Study: 35989585

Group type: EXPERIMENTAL
Intervention: Alcohol (target BrAC = 0.08 g/dl)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 33148481

Group type: EXPERIMENTAL
Intervention: Enalapril and folic acid (10 mg enalapril and 0.8 mg folic acid daily)
Number of subjects: 19644

Group type: COMPARATOR
Intervention: Enalapril alone (10 mg enalapril daily)
Number of subjects: 19644

Group type: COMPARATOR
Intervention: Not receiving folic acid (control group for those with elevated serum calcium)
Number of subjects: 19644
Study: 32086604

Group type: EXPERIMENTAL
Intervention: Contralateral approach
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Ipsilateral laminotomy
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Segmental fusion
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Medial facet cysts
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Intraforaminal facet cysts
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Mediolateral facet cysts
Number of subjects: 111
Study: 34992006

Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Pazopanib 800 mg
Number of subjects: 6

Group type: COMPARATOR
Intervention: TKIs
Number of subjects: 6
Study: 34008422

Group type: EXPERIMENTAL
Intervention: Omentum-preserving gastrectomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Radical gastrectomy with D2 lymphadenectomy
Number of subjects: 0
Study: 35066451

Group type: EXPERIMENTAL
Intervention: Sitagliptin
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Insulin
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 68
Study: 33128806

Group type: EXPERIMENTAL
Intervention: Virtual Reality Exposure (VRE)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prolonged Exposure (PE) therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hyperarousal symptoms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reexperiencing symptoms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Avoidance/numbing symptoms
Number of subjects: 0
Study: 36216355

Group type: EXPERIMENTAL
Intervention: Psychological intervention (M2 group)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Routine preoperative health education (M1 group)
Number of subjects: 89
Study: 33915104

Group type: EXPERIMENTAL
Intervention: PCV‐10
Number of subjects: 347

Group type: EXPERIMENTAL
Intervention: PPV‐23
Number of subjects: 347

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 347
Study: 34719137

Group type: EXPERIMENTAL
Intervention: Palliative Care Always: Hepatology (PCA:Hep) online course
Number of subjects: 39
Study: 32389220

Group type: EXPERIMENTAL
Intervention: Genomic testing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Surveys and telephone check-ins
Number of subjects: 0
Study: 35940597

Group type: EXPERIMENTAL
Intervention: Coleadership model
Number of subjects: 0

Group type: COMPARATOR
Intervention: Singular leadership model
Number of subjects: 0
Study: 33538534

Group type: EXPERIMENTAL
Intervention: Risperidone maintenance treatment (4-8 mg/d)
Number of subjects: 161
Study: 36494619

Group type: EXPERIMENTAL
Intervention: MSnetWork intervention (multidisciplinary care network)
Number of subjects: 950
Study: 33655906

Group type: EXPERIMENTAL
Intervention: Smartphone (SP) group (Relaxation by smartphones)
Number of subjects: 360

Group type: COMPARATOR
Intervention: Control group (No relaxation)
Number of subjects: 360
Study: 32244252

Group type: EXPERIMENTAL
Intervention: Daratumumab-CyBorD
Number of subjects: 28
Study: 33852498

Group type: EXPERIMENTAL
Intervention: High-dose epidural fentanyl (≥100 μg)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Low-dose epidural fentanyl (<100 μg)
Number of subjects: 80
Study: 32146300

Group type: EXPERIMENTAL
Intervention: cRCTs implementation
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Barriers to trial conduct
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Research agenda
Number of subjects: 22
Study: 32997098

Group type: EXPERIMENTAL
Intervention: Low-dose rivaroxaban and aspirin
Number of subjects: 4129

Group type: COMPARATOR
Intervention: Aspirin alone
Number of subjects: 4129
Study: 32013285

Group type: EXPERIMENTAL
Intervention: Paresthesia-based tonic stimulation
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Surgical history
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 174

Group type: COMPARATOR
Intervention: Control group (failed SCS trials)
Number of subjects: 174

Group type: COMPARATOR
Intervention: Number of leads, pain duration, characteristics, and category (nociceptive vs neuropathic)
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Interaction between surgical spine history and lower extremity pain
Number of subjects: 174
Study: 35753877

Group type: EXPERIMENTAL
Intervention: Authentic cervical manipulation
Number of subjects: 31

Group type: COMPARATOR
Intervention: Sham cervical manipulation
Number of subjects: 31
Study: 34341406

Group type: EXPERIMENTAL
Intervention: Galvanization and potassium iodide iontophoresis
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 50
Study: 32740180

Group type: EXPERIMENTAL
Intervention: Hydrocolloid dressing
Number of subjects: 71

Group type: COMPARATOR
Intervention: Current care procedure (without hydrocolloid dressing)
Number of subjects: 71
Study: 33662659

Group type: EXPERIMENTAL
Intervention: 9,000 IU/kg vitamin A
Number of subjects: 360

Group type: COMPARATOR
Intervention: VA supplementation groups
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: 6,000, 9,000, and 12,000 IU/kg vitamin A
Number of subjects: 360
Study: 36308037

Group type: EXPERIMENTAL
Intervention: Standardized skin care regimen including once daily leave-on product application (lipid content 21%)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Skin care as preferred by the parents (Control)
Number of subjects: 160
Study: 33545956

Group type: EXPERIMENTAL
Intervention: Lipi Guben decoction (LPGBD)
Number of subjects: 100
Study: 34882826

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 33319947

Group type: EXPERIMENTAL
Intervention: Dynamic Needle Tip Positioning (DNTP)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Conventional Long-Axis In-Plane (LAX-IP)
Number of subjects: 142
Study: 32684367

Group type: EXPERIMENTAL
Intervention: Integration of GWAS results with gene expression and DNA methylation levels.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Analysis of expression and methylation quantitative trait loci datasets of adult brain and blood.
Number of subjects: 0
Study: 33847575

Group type: COMPARATOR
Intervention: IPACK block
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Genicular nerve block
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 35294546

Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 419

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 419
Study: 32394657

Group type: EXPERIMENTAL
Intervention: Warming acupuncture, 50 min each treatment, once daily, at the interval of 1 day after 4-day treatment, until ovulatory stage.
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group received nuangong yunzi capsules, 3 capsules each time, three times a day, until ovulatory stage.
Number of subjects: 72
Study: 36083983

Group type: EXPERIMENTAL
Intervention: Outdoor residual spraying (ORS) with a capsule suspension of lambda-cyhalothrin for two days in October.
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 12